Parties d'ouvrages collectifs (2)
  1. 1. Loas, G. (2014). Anhedonia and risk of suicide: An overview. In Anhedonia: A Comprehensive Handbook Volume II: Neuropsychiatric and Physical Disorders (pp. 247-253). Springer Netherlands. doi:10.1007/978-94-017-8610-2_11
  2. 2. Loas, G. (2014). Anhedonia in heart disease. In Anhedonia: A Comprehensive Handbook Volume II: Neuropsychiatric and Physical Disorders (pp. 291-299). Springer Netherlands. doi:10.1007/978-94-017-8610-2_14
    3.   Articles dans des revues avec comité de lecture (83)
  3. 1. Bernier, V., Debarge, M.-H., Hein, M., Ammendola, S., Mungo, A., & Loas, G. (2023). Major Depressive Disorder, Inflammation, and Nutrition: A Tricky Pattern? Nutrients, 15(15), 3438. doi:10.3390/nu15153438
  4. 2. Poletti, M., Pelizza, L., Loas, G., Azzali, S., Paterlini, F., Garlassi, S., Scazza, I., Chiri, L. R., Pupo, S., & Raballo, A. (2023). Anhedonia and suicidal ideation in young people with early psychosis: Further findings from the 2-year follow-up of the ReARMS program. Psychiatry research, 323, 115177. doi:10.1016/j.psychres.2023.115177
  5. 3. Hein, M., Wacquier, B., Lanquart, J. P., & Loas, G. (2022). Risk of Cardiovascular Disease in Apnoeic Individuals: Role of Comorbid Insomnia Disorder. Life, 12(7), 944. doi:10.3390/life12070944
  6. 4. Le Corre, P., & Loas, G. (2022). Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection. Frontiers in Pharmacology, 13, 849095. doi:10.3389/fphar.2022.849095
  7. 5. Loas, G., Van De Borne, P., Darquennes, G., & Le Corre, P. (2022). Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension. Pharmaceuticals, 15(3), 380. doi:10.3390/ph15030380
  8. 6. Solibieda, A., Rotsaert, M., & Loas, G. (2021). The interpersonal–psychological theory of suicide in medical students: Comparisons of individuals without suicidality, ideators and planners. International Journal of Environmental Research and Public Health, 18(21), 11526. doi:10.3390/ijerph182111526
  9. 7. Boz, S., Lanquart, J. P., Mungo, A., Delhaye, M., Loas, G., & Hein, M. (2021). Risk of Excessive Daytime Sleepiness Associated to Major Depression in Adolescents. Psychiatric quarterly, 92(4), 1473-1488. doi:10.1007/s11126-021-09922-x
  10. 8. Zeoli, I., Lanquart, J. P., Wacquier, B., Mungo, A., Loas, G., & Hein, M. (2021). Polysomnographic markers of suicidal ideation in untreated unipolar major depressed individuals. International journal of psychophysiology, 166, 19-24. doi:10.1016/j.ijpsycho.2021.05.001
  11. 9. Loas, G., & Le Corre, P. (2021). Update on functional inhibitors of acid sphingomyelinase (Fiasmas) in sars-cov-2 infection. Pharmaceuticals, 14(7), 691. doi:10.3390/ph14070691
  12. 10. Darquennes, G., Le Corre, P., Le Moine, O., & Loas, G. (2021). Association between functional inhibitors of acid sphingomyelinase (Fiasmas) and reduced risk of death in covid-19 patients: A retrospective cohort study. Pharmaceuticals, 14(3), 226. doi:10.3390/ph14030226
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>